NCT02213913 2026-03-11
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
Phase 1/2 Completed
University of Chicago
The Lymphoma Academic Research Organisation
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb
BeOne Medicines